Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05999968
Title Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | DEU


No variant requirements are available.